Canvas access has been restored for our users, but the service reliability remains uncertain. Due to recent events, Canvas has had intermittent outages which are at the discretion of the vendor and may occur during a final exam. Faculty and staff may continue to use Canvas, but we strongly advise faculty and students to prepare a contingency plan for turning in assignments and final exams in the event Canvas access becomes unavailable again.
Instructure, the company that owns Canvas, has provided an FAQ about the incident, which may not answer all your questions. We will share more information if it becomes available.
The Borges Lab is focused on the development of novel vaccines and combination immunotherapy for breast cancer and also on potential biologic differences and therapeutic targets for young women's’ breast cancer.
The Diamond laboratory is focused on the development of novel targeted therapies for triple-negative breast cancer, specifically cell cycle targeting agents and combination immunotherapy.
The Kabos lab translates preclinical findings into novel treatments for patients with breast cancer. The Kabos lab focuses on the role of breast cancer stem cells and tumor microenvironment in treatment resistance.
The Lyons laboratory focuses on mechanisms of semaphorin 7a and lymphatic mediated metastasis of breast cancer. The results of these translational studies have potential to instruct therapy aimed at prevention of breast cancer metastasis.